Form D/A

View Original Filing

Notice of Exempt Offering of Securities

Item 1. Issuer's Identity

Name of Issuer:
MANHATTAN PHARMACEUTICALS INC
Jurisdiction of Incorporation/Organization
DE
Year of Incorporation/Organization
Over Five Years Ago

Previous Name(s)

  • ATLANTIC PHARMACEUTICALS INC.
  • ATLANTIC PHARMACEUTICALS, INC.
  • ATLANTIC TECHNOLOGY VENTURES, INC.
  • ATLANTIC TECHNOLOGY VENTURES INC
  • ATLANTIC PHARMACEUTICALS INC
Entity Type
CORPORATION

Item 2 Issuer Principal Place of Business and Contact Information

787 SEVENTH AVENUE, 48TH FLOOR
NEW YORK, NY 10019
Phone Number: subscription required

Item 3. Related Persons

Name
MICHAEL WEISS
Address
subscription required
Relationship(s)
  • EXECUTIVE OFFICER
  • DIRECTOR
Clarification of Response

Item 3. Related Persons

Name
SEAN POWER
Address
subscription required
Relationship(s)
  • EXECUTIVE OFFICER
Clarification of Response

Item 3. Related Persons

Name
NEIL HERSKOWITZ
Address
subscription required
Relationship(s)
  • DIRECTOR
Clarification of Response

Item 4. Industry Group

PHARMACEUTICALS

Item 5. Issuer Size

Revenue Range (for issuer not specifying "hedge" or "other investment" fund in Item 4 above)
NO REVENUES

Item 6. Federal Exemptions and Exclusions Claimed

Item 7. Type of Filing

Amendment
Date of First Sale in this Offering:
12/30/2011

Item 8. Duration of Offering

Does the issuer intend this offering to last more than one year?
No

Item 9. Type(s) of Securities Offered

  • Equity
  • Option, Warrant or Other Right to Acquire Another Security
  • Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security

Item 10. Business Combination Transaction

Is this offering being made in connection with a business combination transaction, such as a merger, acquisition or exchange offer?
No
Clarification of Response

Item 11. Minimum Investment

Minimum Investment accepted from any outside investor
50000

Item 12. Sales Compensation

Recipient
NONE
Recipient CRD Number
NONE
(Associated) Broker or Dealer)
NATIONAL SECURITIES CORPORATION
(Associated) Broker or Dealer CRD Number
7569
Address
1001 FOURTH AVENUE, SUITE 3750
SEATTLE, WA 98154
States of Solicitation
  • AL
  • AZ
  • AR
  • CA
  • CO
  • CT
  • DE
  • DC
  • FL
  • GA
  • HI
  • ID
  • IL
  • IN
  • IA
  • KS
  • KY
  • LA
  • MD
  • MA
  • MI
  • MN
  • MS
  • MO
  • NE
  • NV
  • NH
  • NJ
  • NM
  • NY
  • NC
  • OH
  • OK
  • OR
  • PA
  • RI
  • SC
  • TN
  • TX
  • UT
  • VT
  • VA
  • WA
  • WV
  • WI

Item 13. Offering and Sales Amounts

Total Offering Amount
25000000
Total Amount Sold
25000000
Total Remaining to be Sold
0
Clarification of Response
THE OFFERING INCLUDES SECURITIES TO BE ACQUIRED UPON THE EXERCISE OR EXCHANGE OF OTHER SECURITIES.

Item 14. Investors

Securities in the offering have been or may be sold to persons who do not qualify as accredited investors,
Number of non-accredited investors who already have invested in the offering:
Total number of investors who already have invested in the offering:
416

Item 15. Sales Commissions and Finders' Fees Expenses

Sales Commissions:
2500000.0 Is an estimate
Finders' Fees
0.0
Clarification of Response

Item 16. Use of Proceeds

Provide the amount of the gross proceeds of the offering that has been or is proposed to be used for payments to any of the persons required to be named as executive officers,directors or promoters in response to Item 3 above.
2412730.0 Is an estimate
Clarification of Response

Signature and Submission

Notice has been signed on behalf by the undersigned duly authorized person
Issuer Name
MANHATTAN PHARMACEUTICALS INC
Issuer Signature
/S/ SEAN POWER
Signer Name
SEAN POWER
Signer Title
CHIEF FINANCIAL OFFICER, TREASURER AND SECRETARY
Signature Date
02/29/2012
WhaleWisdom Logo

Elevate your investments